Instil Bio, Inc.
TIL
$27.70
-$0.88-3.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -137.07% | 48.33% | -54.33% | 38.62% | -88.02% |
| Total Depreciation and Amortization | -32.79% | -17.76% | -7.59% | -1.81% | -4.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 325.96% | -58.74% | 159.94% | -38.66% | 1,709.30% |
| Change in Net Operating Assets | 188.83% | 56.33% | -811.83% | -156.21% | 273.17% |
| Cash from Operations | 60.27% | 47.55% | -89.72% | 26.26% | -7.56% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 26.56% | 6,300.00% | -99.08% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.40% | -35.99% | 74.13% | 23.08% | -25.76% |
| Cash from Investing | -26.07% | -34.39% | 66.27% | 28.93% | -33.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 96.12% | 29.56% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.46% | -- | -- | -- | -- |
| Cash from Financing | -85.46% | 903.77% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 166.15% | -254.76% | 625.00% | 87.30% | -231.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 43.28% | 3,466.10% | -109.10% | 124.88% | -1,047.64% |